Impact BioMedical Inc. (IBO) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.93M |
| Enterprise Value | 15.93M |
| P/E Ratio | -4.76 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 1,432.48 |
| Price/Book Ratio | 4.66 |
| Enterprise/Revenue | 1,432.2 |
| Enterprise/EBITDA | -125 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 22.54 |
| Operating Margin | -145.63 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 32,000 |
| Revenue/Share | 0 |
| Gross Profit | -392,000 |
| EBITDA | -12.51M |
| Net Income | -11.84M |
| Diluted EPS | -0.38 |
Balance Sheet
| Total Cash | 10,000 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.16 |
| Book Value Per Share | 0.13 |
Price History
| 52-Week Change | -29.04 |
| 52-Week High | 0.83 |
| 52-Week Low | 0.37 |
| Moving Average 50 Days | 0.45 |
| Moving Average 200 Days | 0.51 |
Statistics
| Average Volume | 115,370 |
| Shares Outstanding | 107.82M |
| % Held by Institutions | 3.56 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
